Source: International Congress 2015 – Advances in the future treatment of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Shuichiro Maruoka (Tokyo, Japan), Shuichiro Maruoka, Sotaro Shikano, Yasuhiro Gon, Kazumichi Kuroda, Kaori Soda, Eriko Tsuboi, Ikuko Takeshita, Kazufumi Shimizu, Shu Hashimoto. Carbocisteine attenuates influenza virus A replication in the bronchoalveolar lavage fluids of virus-infected mice. Eur Respir J 2015; 46: Suppl. 59, 489

Member's Comments

No comment yet.

Related content which might interest you: Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Characterization of an acute influenza infection in a murine model of allergic asthma and responses to corticosteroid Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Regulation of microRNAs in response to herpes simplex virus type-1 (HSV-1) infection in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 IP-10 is selectively produced in the airways upon respiratory virus infection Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Absence of human rhinovirus and respiratory syncytial virus in the lungs of patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Increased uric acid levels in bronchoalveolar lavage fluid of mice infected with H1N1 influenza Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Type I interferons and IL-15 regulate antiviral cellular responses to rhinovirus infection Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013 Novel experimental model of maintained acute lung injury Source: Annual Congress 2013 –Experimental models in critical care Year: 2013 Broccoli sprout homogenates and live attenuated influenza virus: Effect on peripheral blood natural kill cells Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Involvement of the JAK-STAT3 pathway in a lipopolysaccharide-induced rat model of airway inflammation Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Detection of herpes simplex virus type-1 (HSV-1) in lung tissue and bronchoalveolar lavage fluid (BALF) of patients with fibrotic idiopathic interstitial pneumonias (f-IIPs) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 The role of neutrophils in viral clearance during respiratory syncytial virus (RSV) disease Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects Year: 2013 Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Did the introduction of pneumococcal vaccination in Italy change the BAL positive cultures in children with chronic lung diseases? Source: International Congress 2016 – Paediatric bronchology II Year: 2016 LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013